A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study)
| Autor: | Watanabe, Satoshi, Furuya, Naoki, Nakamura, Atsushi, Shiihara, Jun, Nakachi, Ichiro, Tanaka, Hisashi, Nakao, Mika, Minato, Koichi, Seike, Masahiro, Sasaki, Shinichi, Kisohara, Akira, Takeuchi, Susumu, Honda, Ryoichi, Takamura, Kei, Kagamu, Hiroshi, Yoshimura, Kenichi, Kobayashi, Kunihiko, Kikuchi, Toshiaki |
|---|---|
| Zdroj: | In European Journal of Cancer January 2024 197 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect